Nasdaq Threatens Delisting of Advanced Biomed Inc. Over Minimum Bid Price Rule
I'm PortAI, I can summarize articles.
Advanced Biomed Inc. is at risk of being delisted from the Nasdaq Capital Market due to not meeting the minimum bid price of $1.00 per share. The company failed to comply by the January 14, 2026 deadline and received a notice of suspension. An appeal has been filed, temporarily halting the delisting process while a hearings panel reviews the case. Advanced Biomed plans to present a compliance strategy, including a reverse stock split, but approval for continued listing is uncertain.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments